1. H.P. Acthar Gel (repository corticotropin injection) [prescribing information]. Mallinckrodt ARD, Inc.

2. Baram TZ, Mitchell WG, Tournay A, Snead OC III, Hanson RA, Horton EJ. High-dose corticotropin (ACTH) versus prednisone for infantile spasms: a prospective, randomized, blinded study. Pediatrics. 1996;97(3):375-379.

3. Mallinckrodt ARD, Inc. Peripheral and Central Nervous System Advisory Committee Briefing Document. April 5, 2010.

4. Shields D. Infantile spasms. Child Neurology Foundation website. http://www.childneurologyfoundation.org/disorders/infantile-spasms/. Accessed June 23, 2016.

5. Go CY, Mackay MT, Weiss SK, et al; for Child Neurology Society, American Academy of Neurology. Evidence-based guideline update: medical treatment of infantile spasms. Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2012;78(24):1974-1980.

6. Hrachovy RA, Frost JD Jr. Severe encephalopathic epilepsy in infants: infantile spasms (West syndrome). In: Pellock JM, Bourgeois BFD, Dodson WE, Nordli DR Jr, Sankar R, eds. Pediatric Epilepsy: Diagnosis and Therapy. 3rd ed. New York, NY: Demos Medical Publishing; 2008:249-268.

7. Shields WD. Infantile spasms: little seizures, big consequences. Epilepsy Curr. 2006;6(3):63-69.

8. Epilepsy Foundation of New Jersey. Types of seizures. Epilepsy Foundation of New Jersey website. http://www.efnj.com/resources/about-epilepsy/types-of-seizures/. Accessed June 23, 2016.

9. Wang CJ, Jonas R, Fu CM, Ng CY, Douglass L. Quality-of-care indicators for infantile spasms. J Child Neurol. 2013;28(1):13-20.

10. Center for Drug Evaluation and Research. Approval letter: H.P. Acthar Gel. October 15, 2010.

11. Hrachovy RA, Frost JD Jr, Kellaway P, Zion T. A controlled study of ACTH therapy in infantile spasms. Epilepsia. 1980;21(6):631-636.

12. Snead OC 3rd, Benton JW, Myers GJ. ACTH and prednisone in childhood seizure disorders. Neurology. 1983;33(8):966-970.

13. Snead OC 3rd, Benton JW Jr, Hosey LC, et al. Treatment of infantile spasms with high-dose ACTH: efficacy and plasma levels of ACTH and cortisol. Neurology. 1989;39(8):1027-1031.

14. Data on file: RD-004-00. Mallinckrodt ARD, Inc.

15. Data on file: RD-006-00. Mallinckrodt ARD, Inc.

16. Data on file: RD-016-00. Mallinckrodt ARD, Inc.

17. Knupp KG, Coryell J, Nickels KC, et al. Response to treatment in a prospective national infantile spasms cohort. Ann Neurol. 2016;79(3):475-484.

18. Hrachovy RA, Glaze DG, Frost JD Jr. A retrospective study of spontaneous remission and long-term outcome in patients with infantile spasms. Epilepsia. 1991;32(2):212-214.

19. Catania A, Gatti S, Colombo G, Lipton JM. Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol Rev. 2004;56(1):1-29.

20. Catania A, Lonati C, Sordi A, Carlin A, Leonardi P, Gatti S. The melanocortin system in control of inflammation. ScientificWorldJournal. 2010;10:1840-1853.

21. Brzoska T, Luger TA, Maaser C, Abels C, Böhm M. Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocrine Rev. 2008;29(5):581-602.

22. Gong R. The renaissance of corticotropin therapy in proteinuric nephropathies. Nat Rev Nephrol. 2011;8(2):122-128.

23. Data on file: RD-010-00. Mallinckrodt ARD, Inc.

24. Data on file: RD-011-00. Mallinckrodt ARD, Inc.

25. Mosteller RD. Simplified calculation of body-surface area. N Engl J Med. 1987;317(17):1098.

26. Data on file. Payer information. Mallinckrodt ARD, Inc.